Scholars Central

Review articlePublished 2012

Molecularly Targeted Therapy: Past, Present and Future

Authors: Yoh Dobashi, Akiteru Goto, Maiko Kimura, Tomoyuki Nakano

Chemotherapy: Open Access

Volume 1 · Issue 4 · Pages 1–12

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Cancer is a heterogeneous disease with diverse underlying molecular causes and equally diverse clinical profiles. It has long been a goal to develop cancer therapies that would be distinct and appropriate for each patient. The recent concept of “oncogene addiction” has been very helpful in guiding this path “from the bench to the bed”. The most significant advance in the treatment of cancer in the past few decades has been the introduction of molecularly targeted therapies, such as imatinib for chronic myelogenous leukemia and gefitinib for lung cancer. In addition, many new promising agents have been developed in the laboratory and are now entering clinical testing. Thus, our current challenge is to better understand how to utilize these agents in clinical practice and to better understand the mechanisms of drug resistance that may be encountered. Advances in these areas would allow for more targeted and effective treatment options for cancer patients. This review describes the development of molecularly targeted therapies from the past achievements to current efforts, the insights learned by this effort, the problems encountered in the clinic, and the potential for novel development of next-generation kinase inhibitors.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Chemotherapy: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalChemotherapy: Open Access
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Yoh Dobashi”
  • BylineArticles whose byline prints “Akiteru Goto”
  • BylineArticles whose byline prints “Maiko Kimura”
  • BylineArticles whose byline prints “Tomoyuki Nakano”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels